Clinical trial
Effectiveness of Spinal Cord Stimulation As Therapy for Chemotherapy-Induced Peripheral Neuropathy: a Pilot Trial
NCT03764514 is registered in ClinicalTrials.gov with Prisma Health-Upstate as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Spinal Cord Stimulation As Therapy for Chemotherapy-Induced Peripheral Neuropathy: a Pilot Trial
- Lead sponsor
- Prisma Health-Upstate
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 3, 2018
- Completion date
- May 3, 2022
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy